ArticlePloS one2025
Therapeutic effects of skin repair plus ointment on molecular and morphological changes in burn wounds: A rat model.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin Repair Plus Ointment (Remanco) is an advanced formulation of the traditional Jordanian cream, which has been used for treating burn injuries and has served as an alternative remedy in northern Jordan for several decades. In this study, we sought to investigate the therapeutic effects of Remanco on the healing morphology and molecular alterations associated with burn wounds. This randomized controlled experiment involved 90 Wistar rats (160-170 grams) that were randomly assigned to three groups of 30 rats each. The groups were designated as follows: negative control (burn treated with normal saline), positive control (burn treated with 1% silver sulfadiazine), and tested (burn treated with Remanco cream). Burn injuries were inflicted on the shaved dorsum of the rats using a preheated 30-mm-wide circular copper head device. The burns were treated daily with normal saline, 1% silver sulfadiazine, or Remanco cream for 30 days or until the animals were sacrificed. Gross evaluation, histopathological assessment, and RT-PCR Analysis were conducted to evaluate the efficacy of Remanco cream in promoting wound healing. Although there was no statistically significant difference in wound area measurements or histopathological ratings, the cosmetic appearance of the wound area exhibited a significant improvement in the Remanco cream-treated group. Molecular investigations revealed that the Remanco-treated group demonstrated a significant increase in the levels of two essential growth factors: TGF-beta on day 3 and IGF-1 on day 9, with a p-value less than 0.05. In summary, Remanco cream holds potential for enhancing wound healing in animal models, but further studies are necessary to investigate its potential clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.